Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ixico (IXI) Share Price

Price 11.75p on 27-10-2026 at 16:51:03
Change 1.50p 14.63%
Buy 12.00p
Sell 11.50p
Last Trade: Buy 5,000.00 at 11.98p
Day's Volume: 553,932
Last Close: 11.75p
Open: 10.25p
ISIN: GB00BFXR4C20
Day's Range 10.25p - 12.25p
52wk Range: 6.625p - 12.50p
Market Capitalisation: £25.73m
VWAP: 11.42863p
Shares in Issue: 218.97m

Ixico (IXI) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 5,000 11.98p Ordinary
16:11:55 - 27-Oct-26
Sell* 5,000 11.525p Ordinary
16:11:31 - 27-Oct-26
Sell* 50,000 11.58p Ordinary
16:09:20 - 27-Oct-26
Sell* 1,000 11.58p Ordinary
16:08:33 - 27-Oct-26
Sell* 88 11.50p Ordinary
16:04:06 - 27-Oct-26
Buy* 2,007 11.98p Ordinary
16:01:20 - 27-Oct-26
Unknown* 60,000 11.6222p Ordinary
15:45:43 - 27-Oct-26
Buy* 8 12.50p SI Trade
15:30:15 - 27-Oct-26
Sell* 8,318 12.0109p Ordinary
15:29:55 - 27-Oct-26
Sell* 9,000 12.0033p Ordinary
15:27:09 - 27-Oct-26
See more Ixico trades

Ixico (IXI) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Oct 2026 (Tue) 10.25 12.25 10.25 11.75 553,932
26th Oct 2026 (Mon) 10.00 10.25 10.00 10.25 20,345
23rd Oct 2026 (Fri) 9.50 10.50 9.50 10.00 291,339
22nd Oct 2026 (Thu) 9.25 9.75 9.00 9.75 780,797
21st Oct 2026 (Wed) 8.50 8.50 8.50 8.50 20,815
20th Oct 2026 (Tue) 8.25 9.00 8.50 8.50 1,336,660
19th Oct 2026 (Mon) 7.75 7.75 7.75 7.75 3,306
16th Oct 2026 (Fri) 7.75 7.75 7.75 7.75 58,390
15th Oct 2026 (Thu) 7.75 7.75 7.75 7.75 171
14th Oct 2026 (Wed) 7.75 7.75 7.75 7.75 5,999
13th Oct 2026 (Tue) 7.75 7.75 7.75 7.75 42,414
12th Oct 2026 (Mon) 7.75 7.75 7.75 7.75 17,645
9th Oct 2026 (Fri) 7.75 7.75 7.75 7.75 8,415
8th Oct 2026 (Thu) 7.75 7.75 7.75 7.75 7,684
7th Oct 2026 (Wed) 8.00 8.00 7.75 8.00 137,814
6th Oct 2026 (Tue) 8.00 8.00 8.00 8.00 2,302
5th Oct 2026 (Mon) 7.50 8.00 7.50 8.00 165,113
2nd Oct 2026 (Fri) 7.50 7.50 7.50 7.50 10,787
1st Oct 2026 (Thu) 7.50 7.50 7.50 7.50 1,000
30th Sep 2026 (Wed) 7.50 7.50 7.50 7.50 0
29th Sep 2026 (Tue) 7.50 7.50 7.50 7.50 166,218
28th Sep 2026 (Mon) 7.50 7.50 7.50 7.50 15,381
See more Ixico price history

Ixico (IXI) Regulatory News

Date Source Headline
22nd Oct 2026 7:00 am RNS Alzheimer's contract wins
20th Oct 2026 7:00 am RNS Trading Update
1st Oct 2026 7:00 am RNS-R IXICO present PD research at radiology conference
27th Jul 2026 2:46 pm RNS Share option award
15th Jul 2026 12:01 pm RNS Director/PDMR Shareholding
13th Jul 2026 7:00 am RNS HD Industry Update
7th Jul 2026 7:00 am RNS Trading Update
19th Jun 2026 7:00 am RNS Exercise of Options
8th Jun 2026 7:00 am RNS Scientific advisors & partners update
22nd May 2026 7:00 am RNS-R Company presentation at Mello 2026
See more Ixico regulatory news

Ixico (IXI) Share News

TRADING UPDATES: Synthomer is cash positive; Arbuthnot lifts outlook

22nd Oct 2026 14:33

(Alliance News) - The following is a round-up of business updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Ixico stock rises as forecasts full-year revenue and earnings beat

20th Oct 2026 17:11

(Alliance News) - Ixico PLC on Tuesday said it expects to report market consensus-beating results for the year ended September 30. Read More

WINNERS & LOSERS: Ixico beats expectations; Shearwater wins deal

20th Oct 2026 11:06

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

LONDON MARKET MIDDAY: Oil rises as Iran escalation keeps FTSE subdued

13th Jul 2026 12:13

(Alliance News) - Stock prices in London were lower at midday on Monday, with weakness in technology and financial shares offsetting gains in telecoms stocks, while investors kept a close eye on the latest escalation in the Middle East. Read More

IN BRIEF: Ixico notes ending of Huntington's disease programmes

13th Jul 2026 11:41

Ixico - London-based medical research company, focused on analysing trial data using neuroscience imaging and biomarkers - Says the discontinuation of two Huntington's disease programmes by existing clients reduces its contracted order book by around GBP1.5 million over the next two financial years. Ixico notes it secured GBP8.0 million of new Huntington's disease programme awards in the first half and says its order book remains 21% above the end of financial 2025. It adds that programme cancellations are a normal feature of drug development and reiterates recently upgraded guidance for financial 2026 and its outlook for 2027. Read More

See more Ixico news
FTSE 100 Latest
Value10,686.54
Change-80.79

Login to your account

Forgot Password?

Not Registered